Tag: Cancer: Lung
Treatment for Stage I NSCLC Patients Up From 2000 to 2010
Improved survival for non-small-cell lung cancer patients, driven by better survival in treated patients
2003 to 2014 Saw Drop in Urinary Arsenic in Public Water Users
Reduction occurred after implementation of EPA's maximum contaminant level for arsenic
Uninsurance Down by One-Third for Cancer Diagnoses in 2014
Significant decreases in uninsurance seen across all stages and sites assessed in first year of ACA
Primary, Pulmonary Providers Endorse Lung CA Screening
Key barriers to LCS include inadequate time and staffing, patients having too many illnesses
Checkpoint Inhibitors No Less Safe With Radiation
Combination does not increase immune-related adverse events in metastatic lung cancer patients
Accurate Lung Cancer Staging Depends on Quality Nodal Exam
Difference in exam thoroughness may account for large regional differences in survival
ASTRO: SBRT Prolongs Survival in Non-Small-Cell Lung Cancer
Trial stopped after significant improvement in progression-free survival in metastatic NSCLC
ASTRO: Standard-Dose CRT Beats Higher Dose in Stage III NSCLC
Significantly improved five-year overall survival rates with 60 Gy chemoradiation tx versus high-dose
Expected Burden of Lung Cancer High for People Living With HIV
PLWH who adhere to antiretroviral tx but smoke are substantially more likely to die from lung cancer
Longer Progression-Free Survival for Durvalumab in NSCLC
Longer median progression-free survival from randomization, higher response rate with durvalumab
